A clearer vision for in vivo imaging R Weissleder Nature biotechnology 19 (4), 316-317, 2001 | 4471 | 2001 |
Imaging in the era of molecular oncology R Weissleder, MJ Pittet Nature 452 (7187), 580-589, 2008 | 2833 | 2008 |
Epigenetic memory in induced pluripotent stem cells K Kim, A Doi, B Wen, K Ng, R Zhao, P Cahan, J Kim, MJ Aryee, H Ji, ... Nature 467 (7313), 285-290, 2010 | 2691 | 2010 |
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer MG Harisinghani, J Barentsz, PF Hahn, WM Deserno, S Tabatabaei, ... New England Journal of Medicine 348 (25), 2491-2499, 2003 | 2673 | 2003 |
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions M Nahrendorf, FK Swirski, E Aikawa, L Stangenberg, T Wurdinger, ... The Journal of experimental medicine 204 (12), 3037-3047, 2007 | 2663 | 2007 |
Identification of splenic reservoir monocytes and their deployment to inflammatory sites FK Swirski, M Nahrendorf, M Etzrodt, M Wildgruber, V Cortez-Retamozo, ... Science 325 (5940), 612-616, 2009 | 2650 | 2009 |
Shedding light onto live molecular targets R Weissleder, V Ntziachristos Nature medicine 9 (1), 123-128, 2003 | 2385 | 2003 |
Molecular imaging R Weissleder, U Mahmood Radiology 219 (2), 316-333, 2001 | 2365 | 2001 |
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells M Lewin, N Carlesso, CH Tung, XW Tang, D Cory, DT Scadden, ... Nature biotechnology 18 (4), 410-414, 2000 | 2360 | 2000 |
Restoration of p53 function leads to tumour regression in vivo A Ventura, DG Kirsch, ME McLaughlin, DA Tuveson, J Grimm, L Lintault, ... Nature 445 (7128), 661-665, 2007 | 2176 | 2007 |
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism H Ying, AC Kimmelman, CA Lyssiotis, S Hua, GC Chu, ... Cell 149 (3), 656-670, 2012 | 2079 | 2012 |
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes R Weissleder, CH Tung, U Mahmood, A Bogdanov Nature biotechnology 17 (4), 375-378, 1999 | 2028 | 1999 |
Looking and listening to light: the evolution of whole-body photonic imaging V Ntziachristos, J Ripoll, LV Wang, R Weissleder Nature biotechnology 23 (3), 313-320, 2005 | 1929 | 2005 |
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers JA Engelman, L Chen, X Tan, K Crosby, AR Guimaraes, R Upadhyay, ... Nature medicine 14 (12), 1351-1356, 2008 | 1579 | 2008 |
Superparamagnetic iron oxide: pharmacokinetics and toxicity R Weissleder, DD Stark, BL Engelstad, BR Bacon, CC Compton, ... American Journal of Roentgenology 152 (1), 167-173, 1989 | 1473 | 1989 |
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata FK Swirski, P Libby, E Aikawa, P Alcaide, FW Luscinskas, R Weissleder, ... The Journal of clinical investigation 117 (1), 195-205, 2007 | 1464 | 2007 |
New technologies for analysis of extracellular vesicles H Shao, H Im, CM Castro, X Breakefield, R Weissleder, H Lee Chemical reviews 118 (4), 1917-1950, 2018 | 1438 | 2018 |
Molecular imaging in cancer R Weissleder Science 312 (5777), 1168-1171, 2006 | 1413 | 2006 |
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. R Weissleder, G Elizondo, J Wittenberg, CA Rabito, HH Bengele, ... Radiology 175 (2), 489-493, 1990 | 1385 | 1990 |
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging V Ntziachristos, C Bremer, R Weissleder European radiology 13 (1), 195-208, 2003 | 1355 | 2003 |